What Capital Pathology does

Capital Pathology is a diagnostic pathology laboratory headquartered in Deakin, ACT, Australia, providing comprehensive testing services to medical practitioners (GPs and specialists), private hospitals, and aged care facilities across the ACT and regional New South Wales (Southern Tablelands, Snowy Mountains, and South Coast NSW). Its main Deakin laboratory operates 24 hours and holds Category GX NATA/RCPA accreditation (the highest classification), supported by regional laboratories in Bega and Goulburn and a network of over 40 collection centres. Core testing spans haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, alongside specialised services including cervical (HPV) screening, familial hypercholesterolaemia (FH) genetic testing, STI testing, cardiac services (ECG, Holter), blood bank/transfusion, and commercial/occupational testing. The company is a subsidiary of Sonic Healthcare Limited, Australia's largest pathology group and one of the largest globally, operating under Sonic's federated model with local autonomy.

Technically, the company differentiates through electronic ordering (eOrdering) integrated with Best Practice and Medical Director practice management software, enabling clinicians to generate referrals during consultations; patients receive an SMS barcode within two minutes for scanning at collection centres, including a telehealth-triggered variant. Clinician-facing reporting and workflow tools include Sonic Dx, Webster, and Fetch, complemented by online audit and education tools (HPV Audit, Skin Cancer Audit, CST Audit, Sonic Education). Specialised genetic and DNA testing is delivered via Sonic Genetics (NIPT, reproductive carrier screening) and DNALabs (parentage/relationship testing), cross-referenced within the Sonic network.

The business model is sales-led (referrals from clinicians and institutional clients via a Doctor Service Centre and Client Services team) combined with direct-to-consumer access through collection centres, home visits, and the MyTest results portal. Revenue is transaction-based across several streams: Medicare-rebatable outpatient testing (with a $50 gap cap and bulk billing for concession holders, children under 16, and DVA patients), private/AMA-rate billing for non-Medicare and international patients, no-gap direct billing to health funds, self-funded immunity/infection screening (e.g., Hepatitis B $50, QuantiFERON Gold $75, individual immunity tests $25 each), negotiated corporate/commercial testing, and specialised genetic testing.

Name

Capital Pathology

Legal name

Capital Pathology

Website

https://capitalpath.com.au

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Capital Pathology is a Sonic Healthcare–owned diagnostic pathology laboratory in Deakin, ACT, serving GPs, specialists, private hospitals, aged care facilities, and corporate clients across the ACT and regional NSW through a network of 40-plus collection centres.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industry

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI)

Keywords

• Diagnostic pathology services
• Blood testing laboratory
• Medical collection centres
• Genetic screening services
• Workplace health screening

Headquarters

HQ city

Deakin

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medicare Rebateable Pathology Testing: Capital Pathology bulk bills concession card holders, children under 16, and DVA patients. For other Medicare patients, out-of-pocket costs are capped at $50. Most standard pathology tests are covered under the Medicare Benefits Schedule (MBS). Revenue is derived from Medicare rebates paid per test.
2. Private Patient Billing: Patients without Medicare (overseas visitors, students) are billed at AMA (Australian Medical Association) rates. Patients with health insurance may claim rebates per their insurer coverage. No-gap agreements with major health funds result in direct billing to the fund with no patient out-of-pocket costs.
3. Self-Funded Non-Medicare Pathology: Immunity and infection screening for healthcare employment and clinical placement is self-funded by patients. Tests include Hepatitis B ($50), QuantiFERON Gold for TB ($75), and individual immunity tests ($25 each for Measles, Mumps, Rubella, Varicella). Medicare does not cover these administrative-requirement tests.
4. Corporate / Commercial Pathology Services: Workplace drug and alcohol testing, pre-employment screening, hazardous materials monitoring (heavy metals, PFAS, Q-fever, TB), COVID-19 workplace screening, and corporate health and wellness programs for corporate clients. Fees are negotiated per engagement.
5. Specialised Genetic Testing: Specialised services including NIPT (via Sonic Genetics), DNALabs parentage and relationship testing, and FH genetic testing. Some genetic tests are Medicare rebatable (e.g., reproductive carrier screening), while others are privately billed.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Capital Pathology operates a 24-hour diagnostic pathology laboratory in Deakin, ACT, providing comprehensive testing across haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology. Services are delivered through a network of over 40 collection centres, regional laboratories in Bega and Goulburn, and a courier specimen transport network, serving referring GPs, specialists, private hospitals, aged care facilities, corporate clients, and individual patients across the ACT and regional NSW. The offering includes specialised sub-brands for genetic testing (Sonic Genetics, DNALabs), familial hypercholesterolaemia screening, cervical screening, cardiac services, and workplace health programs.

Product overview

Capital Pathology operates as a comprehensive pathology service provider offering a unified diagnostic platform centered on laboratory testing services. The core offering consists of 24-hour pathology testing across multiple disciplines (haematology, biochemistry, immunology, microbiology, anatomical pathology, cytology) delivered through a network of over 40 collection centres with courier specimen transport. The service portfolio extends through specialized sub-brands including Sonic Genetics for NIPT and reproductive genetic testing, and DNALabs for parentage/relationship DNA testing. Additional modules include electronic ordering (eOrdering) for Best Practice/Medical Director practices, clinical reporting tools (Sonic Dx, Webster, Fetch), cardiac monitoring services (ECG, Holter), corporate/commercial testing services, and immunity screening programs. The company is part of Sonic Healthcare and maintains NATA/ISO 15189 accreditation.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Testing Services Core 24-hour pathology laboratory testing services including haematology, biochemistry, immunology, microbiology, anatomical pathology, and cytology, serving referring GPs, specialists, hospitals, and patients across the ACT and regional NSW.
• Collection Centre Network Network of over 40 collection centres across Canberra and regional NSW (including Southern Tablelands, Snowy Mountains, and South Coast NSW) offering blood collection services, with early morning and weekend hours, online and walk-in appointments, and home visit phlebotomy for eligible patients.
• Courier Specimen Transport Services Specimen transport services with regular multiple daily pickups from hospitals, nursing homes, doctors' practices, and collection centres, plus 24/7 urgent specimen transport from selected hospitals.
• Blood Bank and Transfusion Services Blood bank services including blood typing, Rh factor testing, antibody screening, and transfusion support for hospital patients.
• Cervical Screening Testing HPV-based cervical cancer screening performed every five years for women aged 25-74, detecting high-risk HPV types 16 and 18.
• Cardiac Services ECG recording and interpretation by specialist cardiologists, and Holter monitor service with specialist cardiology reporting.
• Commercial and Corporate Testing Services Corporate and workplace testing services including hazardous materials monitoring (heavy metals, herbicides, PFOS/PFAS), drug and alcohol testing, pre-employment screening, and COVID-19 workplace screening with 12-24 hour result turnaround.
• Familial Hypercholesterolaemia (FH) Genetic Testing Open-access genetic testing for familial hypercholesterolaemia diagnosis, connecting patients with FH specialists via telehealth for diagnostic assessment, informed consent, and cascade family testing.
• DNALabs Parentage and Relationship Testing DNA-based parentage (paternity) and relationship testing for legal, immigration, and peace-of-mind purposes, NATA-accredited to ISO/IEC 17025.
• Sonic Genetics NIPT and Genetic Testing Non-Invasive Prenatal Testing (NIPT) — a DNA-based blood test measuring the chance of common genetic conditions from as early as 10 weeks' gestation, plus reproductive carrier screening, cancer genetics, and pharmacogenomics.
• Immunity and Infection Screening Self-funded testing program for healthcare employment and student clinical placement, including measles, mumps, rubella, varicella, hepatitis B, and tuberculosis (QuantiFERON Gold) screening to meet mandatory health requirements.
• STI Testing Sexually transmitted infection testing services with options for GP referral, sexual health clinic access, or online ordering via SmartHealth platform.

Quantifiable outcome

• Results available within 24 hours for routine tests
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Sonic Healthcare LimitedflagshipStrategic or Co-development PartnerSonic Healthcare Limited is the parent company of Capital Pathology. Sonic Healthcare is Australia's largest pathology provider and one of the largest in the world, operating across Australasia, Europe, and North America with over 2,200 pathologists and approximately 18,000 employees. Capital Pathology operates as part of Sonic's federated model, maintaining local autonomy while benefiting from the group's scale, resources, and international network.
• Best Practice SoftwarecoreTechnology or IntegrationCapital Pathology's electronic ordering (eOrdering) system is integrated with Best Practice and Medical Director practice management software. Clinicians using Best Practice can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients.
• Medical Director (Software)coreTechnology or IntegrationCapital Pathology's electronic ordering (eOrdering) system is integrated with Medical Director practice management software. Clinicians using Medical Director can generate electronic pathology referrals during consultations, triggering SMS delivery of barcodes to patients for scanning at collection centres.
• Sonic GeneticscoreStrategic or Co-development PartnerSonic Genetics is the genetic testing division of Sonic Healthcare, offering NIPT, reproductive carrier screening, cancer genetics, pharmacogenomics, and other genetic tests. Capital Pathology refers patients for these specialised genetic services, providing integrated access to genetic testing within the Sonic network.
• DNALabscoreStrategic or Co-development PartnerDNALabs is the parentage and relationship DNA testing service within Sonic Healthcare. Capital Pathology offers DNALabs parentage and relationship testing through its specialised services. DNALabs has a nationwide collection centre network and NATA-accredited laboratory in Sydney.
• Sonic Commercial PathologycoreStrategic or Co-development PartnerCapital Pathology is part of the wider Sonic Commercial Pathology network, providing corporate and occupational health testing services including drug and alcohol testing, pre-employment screening, and hazardous materials monitoring. The commercial network provides operational expertise for workplace health programs.
• ACT PathologyminorStrategic or Co-development PartnerSeveral Capital Pathology pathologists have trained at or collaborated with ACT Pathology (Canberra Hospital). Dr Ingrid Fewings completed part of her anatomical pathology training at ACT Pathology, and Dr Divya Srivastava completed required training from both Capital Pathology and ACT Pathology before receiving her RCPA fellowship.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Douglass Hanly Moir Pathology: Sonic Healthcare pathology subsidiary serving Sydney and regional NSW with a full anatomic/clinical pathology menu and integrated electronic ordering. Direct peer in scale, scope and Sonic operating model, with overlapping regional NSW catchment to Capital Pathology's southern service area.
• Australian Clinical Labs: ASX-listed national pathology operator (ACL) with collection-centre networks, anatomic/clinical pathology and corporate/occupational testing. Closest non-Sonic direct peer, comparable in scale of collection network and breadth of services.
• Laverty Pathology: Sonic Healthcare pathology subsidiary operating across NSW and ACT with collection centres, electronic ordering and a comparable Medicare/private payer mix. Direct peer in service offering and in overlapping ACT/NSW geography.
• ACT Pathology: Public pathology service for Canberra Hospital and ACT Health. Operates in the same ACT geography as Capital Pathology, serves many of the same referring clinicians (and is a documented training partner for several Capital Pathology pathologists), and competes for hospital and GP referrals.
• Sullivan Nicolaides Pathology: Fellow Sonic Healthcare pathology subsidiary operating a 24-hour central laboratory and large collection-centre network across Queensland and northern NSW. Closest direct peer given shared Sonic operating model, similar collection-centre-led GTM and Medicare-rebate-driven revenue mix.

Broad incumbents

• NSW Health Pathology: Public-sector pathology provider operating across NSW public hospitals and some community collection. Comparable in clinical and anatomic pathology menu and overlapping regional NSW geography, but a public-sector incumbent with a different funding model.
• Healius Pathology: Parent of QML, Dorevitch, Western Diagnostic Pathology and other brands; one of Australia's largest pathology operators. Comparable in core diagnostic pathology offering but broader, multi-brand incumbent rather than a regional specialist.

Others

• DNALabs: NATA-accredited (ISO/IEC 17025) parentage and relationship DNA testing service within Sonic Healthcare, offered through Capital Pathology's collection centres. Sister entity that monetises a specialised service line Capital Pathology hosts but does not directly perform.
• Sonic Genetics: Genetic testing division of Sonic Healthcare, accessed by Capital Pathology patients for NIPT, reproductive carrier screening and other specialised assays. Sister entity rather than competitor, but a key channel partner for Capital Pathology's higher-value genetic revenue.

Emerging players

• 4Cyte Pathology: Privately held Australian pathology operator that has rapidly expanded a bulk-billed collection-centre network across multiple states. Comparable in collection-centre-led outpatient model and Medicare-bulk-bill positioning, and an emerging competitive threat in regional catchments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/capital-pathology-pty-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Capital Pathology